Celldex Therapeutics, Inc. (CLDX)
USD 14.93
(-5.42%)
USD 14.93
(-5.42%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -111.12 Million USD | 304.91% |
| 2022 | 957 Thousand USD | -39.55% |
| 2021 | 1.58 Million USD | 104.51% |
| 2020 | -35.11 Million USD | 10.19% |
| 2019 | -39.09 Million USD | 31.3% |
| 2018 | -56.91 Million USD | 31.78% |
| 2017 | -83.42 Million USD | 12.4% |
| 2016 | -95.24 Million USD | -6583.32% |
| 2015 | 1.46 Million USD | 101.49% |
| 2014 | -98.29 Million USD | -5631.51% |
| 2013 | 1.77 Million USD | 316.16% |
| 2012 | 427 Thousand USD | 192.47% |
| 2011 | 146 Thousand USD | -99.58% |
| 2010 | 34.71 Million USD | 411.81% |
| 2009 | 6.78 Million USD | -9.02% |
| 2008 | 7.45 Million USD | 46.1% |
| 2007 | 5.1 Million USD | 3.48% |
| 2006 | 4.93 Million USD | 59.67% |
| 2005 | 3.08 Million USD | -54.97% |
| 2004 | 6.85 Million USD | 48.04% |
| 2003 | 4.63 Million USD | -30.48% |
| 2002 | 6.66 Million USD | 101.38% |
| 2001 | 3.3 Million USD | 127.82% |
| 2000 | 1.45 Million USD | -33.87% |
| 1999 | 2.19 Million USD | -15.53% |
| 1998 | 2.6 Million USD | 73.33% |
| 1997 | 1.5 Million USD | 25.0% |
| 1996 | 1.2 Million USD | -57.14% |
| 1995 | 2.8 Million USD | -51.72% |
| 1994 | 5.8 Million USD | -22.67% |
| 1993 | 7.5 Million USD | 25.0% |
| 1992 | 6 Million USD | -34.07% |
| 1991 | 9.1 Million USD | -9.9% |
| 1990 | 10.1 Million USD | 44.29% |
| 1989 | 7 Million USD | 62.79% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.7 Million USD | 374.8% |
| 2024 Q1 | -619 Thousand USD | -118.36% |
| 2023 Q3 | 750 Thousand USD | 253.69% |
| 2023 Q1 | 241 Thousand USD | -74.36% |
| 2023 Q4 | 3.37 Million USD | 349.6% |
| 2023 Q2 | -488 Thousand USD | -302.49% |
| 2023 FY | 3.87 Million USD | 304.91% |
| 2022 FY | 957 Thousand USD | -39.55% |
| 2022 Q1 | -16.88 Million USD | -17.69% |
| 2022 Q2 | -578 Thousand USD | 96.58% |
| 2022 Q3 | -21.16 Million USD | -3561.76% |
| 2022 Q4 | 940 Thousand USD | 104.44% |
| 2021 Q3 | -13.4 Million USD | -51.01% |
| 2021 Q4 | -14.34 Million USD | -7.02% |
| 2021 FY | 1.58 Million USD | 104.51% |
| 2021 Q2 | -8.87 Million USD | 26.25% |
| 2021 Q1 | -12.03 Million USD | -417.97% |
| 2020 FY | -35.11 Million USD | 10.19% |
| 2020 Q2 | -9.46 Million USD | -5.6% |
| 2020 Q3 | -10.04 Million USD | -6.03% |
| 2020 Q4 | 3.78 Million USD | 137.7% |
| 2020 Q1 | -8.96 Million USD | 5.13% |
| 2019 Q3 | -10.55 Million USD | -12.69% |
| 2019 FY | -39.09 Million USD | 31.3% |
| 2019 Q1 | -9.72 Million USD | -15.2% |
| 2019 Q2 | -9.36 Million USD | 3.7% |
| 2019 Q4 | -9.45 Million USD | 10.45% |
| 2018 Q3 | -10.97 Million USD | 41.25% |
| 2018 Q4 | -8.44 Million USD | 23.08% |
| 2018 Q1 | -17.8 Million USD | 11.0% |
| 2018 Q2 | -18.68 Million USD | -4.93% |
| 2018 FY | -56.91 Million USD | 31.78% |
| 2017 Q2 | -21.17 Million USD | 12.73% |
| 2017 Q4 | -20 Million USD | -11.21% |
| 2017 FY | -83.42 Million USD | 12.4% |
| 2017 Q1 | -24.25 Million USD | -1395.19% |
| 2017 Q3 | -17.99 Million USD | 15.02% |
| 2016 Q2 | -24.32 Million USD | 6.97% |
| 2016 FY | -95.24 Million USD | -6583.32% |
| 2016 Q4 | 1.87 Million USD | 108.22% |
| 2016 Q1 | -26.14 Million USD | -18.25% |
| 2016 Q3 | -22.78 Million USD | 6.3% |
| 2015 FY | 1.46 Million USD | 101.49% |
| 2015 Q1 | -24.63 Million USD | 3.56% |
| 2015 Q4 | -22.11 Million USD | 6.43% |
| 2015 Q2 | -24.31 Million USD | 1.33% |
| 2015 Q3 | -23.63 Million USD | 2.81% |
| 2014 Q2 | -23.5 Million USD | 2.67% |
| 2014 Q4 | -25.54 Million USD | -1.85% |
| 2014 FY | -98.29 Million USD | -5631.51% |
| 2014 Q1 | -24.15 Million USD | -1309.22% |
| 2014 Q3 | -25.08 Million USD | -6.7% |
| 2013 FY | 1.77 Million USD | 316.16% |
| 2013 Q1 | 80 Thousand USD | -16.67% |
| 2013 Q4 | -1.71 Million USD | 91.18% |
| 2013 Q3 | -19.43 Million USD | -29.64% |
| 2013 Q2 | -14.99 Million USD | -18841.25% |
| 2012 Q1 | 89 Thousand USD | 17.11% |
| 2012 Q4 | 96 Thousand USD | -10.28% |
| 2012 FY | 427 Thousand USD | 192.47% |
| 2012 Q3 | 107 Thousand USD | -21.32% |
| 2012 Q2 | 136 Thousand USD | 52.81% |
| 2011 Q3 | 45 Thousand USD | 309.09% |
| 2011 FY | 146 Thousand USD | -99.58% |
| 2011 Q1 | 14 Thousand USD | -99.95% |
| 2011 Q4 | 76 Thousand USD | 68.89% |
| 2011 Q2 | 11 Thousand USD | -21.43% |
| 2010 Q3 | 1.19 Million USD | -2.38% |
| 2010 Q2 | 1.21 Million USD | -12.05% |
| 2010 Q4 | 30.92 Million USD | 2498.4% |
| 2010 Q1 | 1.38 Million USD | 137.83% |
| 2010 FY | 34.71 Million USD | 411.81% |
| 2009 FY | 6.78 Million USD | -9.02% |
| 2009 Q1 | 3.73 Million USD | 24.87% |
| 2009 Q2 | 2.68 Million USD | -28.05% |
| 2009 Q3 | 4.03 Million USD | 50.09% |
| 2009 Q4 | -3.66 Million USD | -190.92% |
| 2008 Q3 | 2.35 Million USD | 20.21% |
| 2008 FY | 7.45 Million USD | 46.1% |
| 2008 Q1 | 147.39 Thousand USD | 104.55% |
| 2008 Q4 | 2.98 Million USD | 26.73% |
| 2008 Q2 | 1.96 Million USD | 1230.83% |
| 2007 Q4 | -3.23 Million USD | -371.83% |
| 2007 Q1 | -3.77 Million USD | -1093.47% |
| 2007 Q3 | 1.19 Million USD | 18.04% |
| 2007 FY | 5.1 Million USD | 3.48% |
| 2007 Q2 | 1 Million USD | 126.73% |
| 2006 Q4 | 380.13 Thousand USD | 12.13% |
| 2006 FY | 4.93 Million USD | 59.67% |
| 2006 Q1 | -642.22 Thousand USD | -201.25% |
| 2006 Q2 | 505.47 Thousand USD | 178.71% |
| 2006 Q3 | 338.99 Thousand USD | -32.94% |
| 2005 FY | 3.08 Million USD | -54.97% |
| 2005 Q4 | 634.3 Thousand USD | -25.05% |
| 2005 Q3 | 846.32 Thousand USD | 32.83% |
| 2005 Q2 | 637.16 Thousand USD | -34.35% |
| 2005 Q1 | 970.55 Thousand USD | -59.68% |
| 2004 FY | 6.85 Million USD | 48.04% |
| 2004 Q2 | 893 Thousand USD | -70.53% |
| 2004 Q4 | 2.4 Million USD | 356.27% |
| 2004 Q3 | 527.6 Thousand USD | -40.92% |
| 2004 Q1 | 3.03 Million USD | 253.35% |
| 2003 Q1 | 681.7 Thousand USD | -11.44% |
| 2003 Q2 | 1.07 Million USD | 58.19% |
| 2003 FY | 4.63 Million USD | -30.48% |
| 2003 Q3 | 2.01 Million USD | 86.86% |
| 2003 Q4 | 857.7 Thousand USD | -57.44% |
| 2002 Q2 | 625.8 Thousand USD | -7.59% |
| 2002 Q4 | 769.8 Thousand USD | -83.08% |
| 2002 Q1 | 677.2 Thousand USD | -26.84% |
| 2002 Q3 | 4.55 Million USD | 627.09% |
| 2002 FY | 6.66 Million USD | 101.38% |
| 2001 Q2 | 817.6 Thousand USD | -41.32% |
| 2001 Q3 | 717.1 Thousand USD | -12.29% |
| 2001 Q4 | 925.6 Thousand USD | 29.08% |
| 2001 FY | 3.3 Million USD | 127.82% |
| 2001 Q1 | 1.39 Million USD | 188.47% |
| 2000 FY | 1.45 Million USD | -33.87% |
| 2000 Q2 | 315.3 Thousand USD | -7.02% |
| 2000 Q1 | 339.1 Thousand USD | 252.13% |
| 2000 Q3 | 315.1 Thousand USD | -0.06% |
| 2000 Q4 | 483 Thousand USD | 53.28% |
| 1999 Q3 | 600 Thousand USD | -40.0% |
| 1999 FY | 2.19 Million USD | -15.53% |
| 1999 Q1 | 500 Thousand USD | -54.55% |
| 1999 Q4 | 96.3 Thousand USD | -83.95% |
| 1999 Q2 | 1 Million USD | 100.0% |
| 1998 Q1 | 500 Thousand USD | 25.0% |
| 1998 Q2 | 400 Thousand USD | -20.0% |
| 1998 Q3 | 600 Thousand USD | 50.0% |
| 1998 FY | 2.6 Million USD | 73.33% |
| 1998 Q4 | 1.1 Million USD | 83.33% |
| 1997 Q3 | 200 Thousand USD | -75.0% |
| 1997 Q1 | 200 Thousand USD | -33.33% |
| 1997 Q2 | 800 Thousand USD | 300.0% |
| 1997 Q4 | 400 Thousand USD | 100.0% |
| 1997 FY | 1.5 Million USD | 25.0% |
| 1996 Q1 | 400 Thousand USD | -42.86% |
| 1996 FY | 1.2 Million USD | -57.14% |
| 1996 Q4 | 300 Thousand USD | 0.0% |
| 1996 Q3 | 300 Thousand USD | 0.0% |
| 1996 Q2 | 300 Thousand USD | -25.0% |
| 1995 Q1 | 900 Thousand USD | 28.57% |
| 1995 Q2 | 800 Thousand USD | -11.11% |
| 1995 FY | 2.8 Million USD | -51.72% |
| 1995 Q4 | 700 Thousand USD | 75.0% |
| 1995 Q3 | 400 Thousand USD | -50.0% |
| 1994 Q3 | 1.2 Million USD | -33.33% |
| 1994 Q2 | 1.8 Million USD | -10.0% |
| 1994 Q1 | 2 Million USD | 17.65% |
| 1994 FY | 5.8 Million USD | -22.67% |
| 1994 Q4 | 700 Thousand USD | -41.67% |
| 1993 Q2 | 2.3 Million USD | 21.05% |
| 1993 Q4 | 1.7 Million USD | -5.56% |
| 1993 Q1 | 1.9 Million USD | 0.0% |
| 1993 Q3 | 1.8 Million USD | -21.74% |
| 1993 FY | 7.5 Million USD | 25.0% |
| 1992 Q1 | 2.2 Million USD | -21.43% |
| 1992 Q2 | 2 Million USD | -9.09% |
| 1992 FY | 6 Million USD | -34.07% |
| 1992 Q3 | 2.8 Million USD | 40.0% |
| 1991 Q3 | 1.4 Million USD | 0.0% |
| 1991 FY | 9.1 Million USD | -9.9% |
| 1991 Q2 | 1.4 Million USD | -33.33% |
| 1991 Q1 | 2.1 Million USD | -8.7% |
| 1991 Q4 | 2.8 Million USD | 100.0% |
| 1990 Q1 | 3.2 Million USD | 0.0% |
| 1990 FY | 10.1 Million USD | 44.29% |
| 1990 Q4 | 2.3 Million USD | -4.17% |
| 1990 Q3 | 2.4 Million USD | 9.09% |
| 1990 Q2 | 2.2 Million USD | -31.25% |
| 1989 Q4 | 3.2 Million USD | 33.33% |
| 1989 Q1 | 2.3 Million USD | 21.05% |
| 1989 FY | 7 Million USD | 62.79% |
| 1989 Q3 | 2.4 Million USD | 14.29% |
| 1989 Q2 | 2.1 Million USD | -8.7% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | 392.25% |
| Alkermes plc | 1.37 Billion USD | 108.084% |
| Agenus Inc. | 139.61 Million USD | 179.596% |
| Aptorum Group Limited | -1.11 Million USD | -9869.426% |
| Ardelyx, Inc. | 106.66 Million USD | 204.188% |
| Dyadic International, Inc. | 922.95 Thousand USD | 12140.431% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 627.648% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -63458.736% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -731.93% |
| Novavax, Inc. | 639.93 Million USD | 117.365% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -137.255% |
| Pyxis Oncology, Inc. | -2 Million USD | -5456.4% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -21405.343% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 683.564% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -251389.092% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -20986.907% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | -13.145% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 13956.359% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -135421.951% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 182.153% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 1511.866% |
| C4 Therapeutics, Inc. | -96.95 Million USD | -14.624% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 107.321% |
| AlloVir, Inc. | -398 Thousand USD | -27821.608% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 146.162% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 26309.434% |
| Bicycle Therapeutics plc | -129.52 Million USD | 14.2% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 92706.667% |
| ChromaDex Corporation | 50.78 Million USD | 318.842% |
| Chimerix, Inc. | 324 Thousand USD | 34398.765% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -256.549% |
| Caribou Biosciences, Inc. | -77.59 Million USD | -43.21% |
| CRISPR Therapeutics AG | 240.95 Million USD | 146.12% |
| Precision BioSciences, Inc. | 40.47 Million USD | 374.58% |
| Fate Therapeutics, Inc. | -98.16 Million USD | -13.208% |
| Fortress Biotech, Inc. | 57.85 Million USD | 292.087% |
| Fortress Biotech, Inc. | 57.85 Million USD | 292.087% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 770.375% |
| ImmuCell Corporation | 4.39 Million USD | 2627.771% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | -4.716% |
| Immix Biopharma, Inc. | -5468.00 USD | -2032233.577% |
| Incyte Corporation | 3.44 Billion USD | 103.23% |
| Innoviva, Inc. | 261.06 Million USD | 142.567% |
| IO Biotech, Inc. | -756 Thousand USD | -14599.471% |
| Jaguar Health, Inc. | 7.72 Million USD | 1538.736% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -16636.145% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 192.798% |
| ContextLogic Inc. | 59 Million USD | 288.353% |
| MiMedx Group, Inc. | 266.84 Million USD | 141.645% |
| MEI Pharma, Inc. | 49.32 Million USD | 325.288% |
| NextCure, Inc. | -3.68 Million USD | -2916.504% |
| Onconetix, Inc. | -1.12 Million USD | -9759.071% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -283.623% |
| Opthea Limited | 21.72 Thousand USD | 511739.042% |
| Psyence Biomedical Ltd. | -240.00 USD | -46303233.333% |
| Vaxcyte, Inc. | -75 Million USD | -48.171% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -193752.702% |
| Precigen, Inc. | 106 Thousand USD | 104937.736% |
| Pharming Group N.V. | 220.1 Million USD | 150.489% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 21678.252% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 11113.677% |
| PureTech Health plc | -1.6 Million USD | -6832.502% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 201.235% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 38.741% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -145.18% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -405.426% |
| Acelyrin, Inc. | -115 Thousand USD | -96533.043% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -1105541.23% |
| Summit Therapeutics Inc. | -2.05 Million USD | -5320.878% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -19361.996% |
| Senti Biosciences, Inc. | -2.68 Million USD | -4041.931% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 2843.224% |
| Elevation Oncology, Inc. | -39 Thousand USD | -284843.59% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -2216.132% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -2719.042% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 481.503% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 22504.839% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -201950.909% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 206.752% |
| Seer, Inc. | 7.02 Million USD | 1681.443% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 2638.328% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 615.795% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -93686.026% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -77448.656% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 18347.619% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 192.242% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 135.428% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -2222460.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 4417.327% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -218914.584% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 478.154% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -47800.0% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -22486.992% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -1465.624% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -23317.8% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -1068438.462% |
| Soligenix, Inc. | 97.31 Thousand USD | 114298.806% |
| Century Therapeutics, Inc. | -10.8 Million USD | -928.106% |
| Kura Oncology, Inc. | -849 Thousand USD | -12989.282% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -65.606% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -75497.279% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 212.206% |
| Autolus Therapeutics plc | -4.86 Million USD | -2183.296% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 368.516% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -66047.619% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 217.319% |
| GRI Bio, Inc. | 10.84 Million USD | 1125.071% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 4475.142% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -1179.245% |
| IGM Biosciences, Inc. | -211.66 Million USD | 47.497% |
| INmune Bio, Inc. | 155 Thousand USD | 71795.484% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 279.415% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -7277.592% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -17037.376% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -379513.309% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 27743.781% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -5467.535% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -35404.153% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 217.644% |
| Verastem, Inc. | -62 Thousand USD | -179138.71% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 4663.778% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -42477.778% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 3771.226% |
| Histogen Inc. | 3.76 Million USD | 3048.474% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 19387.062% |
| Surrozen, Inc. | -27.23 Million USD | -308.109% |
| Organovo Holdings, Inc. | -5.38 Million USD | -1962.127% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -9123.159% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -333.298% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 654.199% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -5612425.253% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 1931.854% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -165439.021% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 171.792% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 76319.479% |
| Apollomics, Inc. | 127 Thousand USD | 87602.362% |
| Amarin Corporation plc | 165.54 Million USD | 167.13% |
| Mesoblast Limited | -9.81 Million USD | -1032.226% |
| Turnstone Biologics Corp. | 16.5 Million USD | 773.258% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | -0.578% |
| Synaptogenix, Inc. | -6347.00 USD | -1750774.429% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -217798.039% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 168.867% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 106.322% |
| Better Therapeutics, Inc. | -2.72 Million USD | -3972.114% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 0.921% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 132.87% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -974023.422% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -1675.208% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -9929.603% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 1618.557% |
| Insmed Incorporated | 239.63 Million USD | 146.374% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 3205.869% |
| OmniAb, Inc. | 14.66 Million USD | 857.674% |
| Alector, Inc. | -95.05 Million USD | -16.912% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 188.463% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -155.684% |
| Zai Lab Limited | 170.9 Million USD | 165.024% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 235.726% |
| Aura Biosciences, Inc. | -1.29 Million USD | -8481.313% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 85583.077% |
| Immunic, Inc. | -111 Thousand USD | -100015.315% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 800.946% |
| Veracyte, Inc. | 248.14 Million USD | 144.783% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 98.41% |
| FibroGen, Inc. | 128.9 Million USD | 186.21% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -19703446.099% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -852.508% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 103.27% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 28667.609% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 131.273% |
| TG Therapeutics, Inc. | 219.1 Million USD | 150.718% |
| Galecto, Inc. | -830 Thousand USD | -13288.916% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -7923.682% |
| Fortrea Holdings Inc. | 424 Million USD | 126.209% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | -28.968% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -19499.295% |
| XBiotech Inc. | -1.74 Million USD | -6272.018% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -9929.603% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -139.134% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -47.123% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 251.394% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 761.358% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 128.565% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -123.836% |
| Vaxxinity, Inc. | -2.23 Million USD | -4874.396% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 134.01% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -881.363% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 554.493% |
| NexImmune, Inc. | -1.02 Million USD | -10742.052% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 2058025.926% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -1463.937% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.983% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -166192.068% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -3029.485% |
| Ainos, Inc. | -253.73 Thousand USD | -43697.22% |
| Pluri Inc. | 322 Thousand USD | 34611.801% |
| Prothena Corporation plc | -129.2 Million USD | 13.988% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 320.387% |
| Celularity Inc. | 6.75 Million USD | 1745.122% |
| Rallybio Corporation | -150 Thousand USD | -73985.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | -240.81% |
| MeiraGTx Holdings plc | 287 Thousand USD | 38820.557% |
| Omeros Corporation | -69.77 Million USD | -59.257% |
| Humacyte, Inc. | -76.55 Million USD | -45.17% |
| Immunocore Holdings plc | 248.39 Million USD | 144.739% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -632.599% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 278.141% |
| Blueprint Medicines Corporation | 236.58 Million USD | 146.972% |
| CalciMedica, Inc. | -58 Thousand USD | -191500.0% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -7692.987% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 482.475% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -3807.454% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -260.045% |
| Pulmatrix, Inc. | -8.22 Million USD | -1251.922% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -9398.12% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -27751.629% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 72.134% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 4103.769% |
| Cytokinetics, Incorporated | -322.59 Million USD | 65.552% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 12990.309% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -32488.856% |
| Vor Biopharma Inc. | -3.49 Million USD | -3082.36% |
| Roivant Sciences Ltd. | 109.23 Million USD | 201.733% |
| Evogene Ltd. | 1.39 Million USD | 8043.388% |
| ProKidney Corp. | -3.16 Million USD | -3406.721% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -153.07% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 1720.65% |
| CorMedix Inc. | -205.56 Thousand USD | -53960.575% |
| BioLineRx Ltd. | 1.1 Million USD | 10129.603% |
| Tango Therapeutics, Inc. | -78.67 Million USD | -41.257% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -336651.515% |
| Atai Life Sciences N.V. | -5000.00 USD | -2222460.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -91093.921% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -115658.333% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -7900.576% |
| Sagimet Biosciences Inc. | 2 Million USD | 5656.4% |
| MediciNova, Inc. | 979.7 Thousand USD | 11443.006% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | -31.795% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -117427.365% |
| GeoVax Labs, Inc. | -20.72 Million USD | -436.312% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 145.445% |
| Biomea Fusion, Inc. | -4.2 Million USD | -2545.275% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 112.739% |
| Mereo BioPharma Group plc | 7.42 Million USD | 1596.472% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -35747.742% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -925966.667% |
| Absci Corporation | -41.84 Million USD | -165.545% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -2222460.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | -45.507% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -4415.563% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 151.993% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -11709.564% |
| Allakos Inc. | -6.14 Million USD | -1709.608% |
| Imunon, Inc. | -720 Thousand USD | -15334.337% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -61.064% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 123.351% |
| BioAtla, Inc. | -103.73 Million USD | -7.131% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -974023.422% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -62331.461% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 54.234% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -35632.476% |
| XOMA Corporation | 3.86 Million USD | 2978.218% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -58.562% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 851.169% |
| aTyr Pharma, Inc. | -2.38 Million USD | -4553.601% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 991.878% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -383100.0% |
| Viridian Therapeutics, Inc. | -1 Million USD | -10924.603% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 854830869.231% |
| Akari Therapeutics, Plc | -4000.00 USD | -2778100.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 117.448% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 57174.183% |
| UroGen Pharma Ltd. | 73.35 Million USD | 251.5% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -316.303% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 957274.849% |
| Orgenesis Inc. | -5.72 Million USD | -1841.1% |
| Entera Bio Ltd. | -56 Thousand USD | -198342.857% |
| GH Research PLC | -315 Thousand USD | -35178.73% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -58697.884% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -21067.238% |
| Xencor, Inc. | -85.26 Million USD | -30.34% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -50189.397% |
| Replimune Group, Inc. | -2.65 Million USD | -4085.612% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -10999.082% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 162.486% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 57174.183% |
| Portage Biotech Inc. | -54 Thousand USD | -205692.593% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -117427.365% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -29376.923% |
| OncoCyte Corporation | 413 Thousand USD | 27007.506% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -2472158.065% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -50057557.658% |
| Purple Biotech Ltd. | -196 Thousand USD | -56597.959% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 1339.161% |
| scPharmaceuticals Inc. | 9.78 Million USD | 1236.046% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -963.939% |
| HilleVax, Inc. | -2.15 Million USD | -5054.36% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -114464.948% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -740555.825% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -16535.928% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -483065.217% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -1480390.69% |
| Savara Inc. | -44.26 Million USD | -151.069% |
| Curis, Inc. | 9.81 Million USD | 1232.688% |
| Daré Bioscience, Inc. | 2.76 Million USD | 4112.534% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -88953.435% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -6327.299% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -48640.351% |
| BeiGene, Ltd. | 2.07 Billion USD | 105.346% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -3874.677% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 72.195% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 296.034% |
| Erasca, Inc. | -3.73 Million USD | -2877.706% |
| bluebird bio, Inc. | -4.03 Million USD | -2657.519% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -393719.548% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 105.835% |
| DBV Technologies S.A. | 15.72 Million USD | 806.562% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -393719.548% |
| Moderna, Inc. | 2.15 Billion USD | 105.157% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -12045.137% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 1488.059% |
| Molecular Templates, Inc. | 50.39 Million USD | 320.514% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -20632.836% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 183.063% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -1686.05% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -182.459% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -2997.213% |
| MacroGenics, Inc. | 50.52 Million USD | 319.938% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -1722.368% |
| Prime Medicine, Inc. | -147.9 Million USD | 24.865% |
| Aditxt, Inc. | -111.66 Thousand USD | -99423.554% |
| Adagene Inc. | 18.11 Million USD | 713.577% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 22872.131% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 179.263% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 170.407% |
| SciSparc Ltd. | 2.19 Million USD | 5160.474% |
| Vericel Corporation | 135.57 Million USD | 181.967% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -443542.461% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -358585.688% |
| Generation Bio Co. | -73.91 Million USD | -50.354% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -25329.748% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 303.46% |
| Invivyd, Inc. | -2.02 Million USD | -5379.684% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 63.061% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -107334.405% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 215.316% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 213.064% |
| ADMA Biologics, Inc. | 88.21 Million USD | 225.97% |
| Clene Inc. | 533 Thousand USD | 20949.531% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 560.936% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -11512.121% |
| GeoVax Labs, Inc. | -20.72 Million USD | -436.312% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 5689.94% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -57089.32% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 323.126% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -1466.949% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -13192.823% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 233.223% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 152096.936% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 309.037% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 35.834% |
| Trevena, Inc. | 1.45 Million USD | 7737.663% |
| Surrozen, Inc. | -27.23 Million USD | -308.109% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -31381.02% |
| Cingulate Inc. | -582.91 Thousand USD | -18964.088% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -358377.419% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -464.13% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -1467905.284% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -12513.848% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 116.325% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -11147.773% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -197138.295% |
| Kronos Bio, Inc. | 1.37 Million USD | 8199.708% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -107.073% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -37957.534% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -22657.488% |
| ImmunityBio, Inc. | -17.89 Million USD | -521.174% |
| Korro Bio, Inc. | -3.63 Million USD | -2961.377% |
| Kineta, Inc. | 5.43 Million USD | 2145.426% |
| BioVie Inc. | -229.37 Thousand USD | -48347.752% |
| Codexis, Inc. | 57.33 Million USD | 293.826% |
| Celularity Inc. | 6.75 Million USD | 1745.122% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 2869.2% |
| Celcuity Inc. | -142.77 Thousand USD | -77735.99% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 219763.965% |
| Cibus, Inc. | 1.42 Million USD | 7914.909% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -29613.369% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -384.873% |
| IN8bio, Inc. | -2.5 Million USD | -4343.343% |
| Kodiak Sciences Inc. | -25.94 Million USD | -328.288% |
| Annexon, Inc. | -3.26 Million USD | -3301.53% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -5336.791% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -166.258% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 17463.75% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 114.274% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 164.253% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -5748.842% |
| Arcellx, Inc. | 108.27 Million USD | 202.631% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -243.316% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 240.306% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -425.378% |
| Moolec Science SA | -143.3 Thousand USD | -77446.492% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -162.602% |
| Geron Corporation | -123.5 Million USD | 10.02% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 3480.834% |
| Royalty Pharma plc | 1.79 Billion USD | 106.195% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -58.55% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -3076533.444% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 48126.068% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 0.257% |
| Humacyte, Inc. | -76.55 Million USD | -45.17% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -11607.864% |
| 89bio, Inc. | -273 Thousand USD | -40606.227% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -8740.732% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -13004.717% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -90247.967% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 10031.01% |
| Notable Labs, Ltd. | 113 Thousand USD | 98443.363% |
| Liquidia Corporation | 14.6 Million USD | 861.151% |
| Mustang Bio, Inc. | -2.22 Million USD | -4894.517% |
| Immunovant, Inc. | -231 Thousand USD | -48007.359% |
| Quantum-Si incorporated | 488 Thousand USD | 22872.131% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -100.018% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -370326.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 6068.206% |
| Acasti Pharma Inc. | -11 Thousand USD | -1010154.545% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -54210.248% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -17037.376% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 33.66% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 9894.638% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -29067.454% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -5575.587% |
| PepGen Inc. | -1.18 Million USD | -9285.811% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -87402.362% |
| United Therapeutics Corporation | 2.07 Billion USD | 105.369% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -385.339% |
| Solid Biosciences Inc. | -76.56 Million USD | -45.146% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -134465.225% |
| Immuneering Corporation | -764.13 Thousand USD | -14442.923% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 167804.938% |
| Belite Bio, Inc | -399 Thousand USD | -27751.629% |
| XOMA Corporation | 3.86 Million USD | 2978.218% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -454.642% |
| Bionomics Limited | -434.44 Thousand USD | -25479.067% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -10247.114% |
| uniQure N.V. | 2.21 Million USD | 5117.065% |
| Cassava Sciences, Inc. | -89.42 Million USD | -24.272% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | -20.701% |
| Forte Biosciences, Inc. | -9000.00 USD | -1234655.556% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -13208.743% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -25329.748% |
| Altimmune, Inc. | -65.37 Million USD | -69.991% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 130.696% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -10247.114% |
| Compugen Ltd. | 31.45 Million USD | 453.292% |
| Peak Bio, Inc. | 367.76 Thousand USD | 30316.794% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 553.288% |
| Benitec Biopharma Inc. | 108 Thousand USD | 102996.296% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -142371.795% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -9137.573% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -5999.232% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -93284.874% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -9137.573% |
| Instil Bio, Inc. | -4.75 Million USD | -2236.585% |
| argenx SE | 1.1 Billion USD | 110.025% |
| Immunome, Inc. | -8.9 Million USD | -1147.648% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -5779.788% |
| Verona Pharma plc | -679.62 Thousand USD | -16251.394% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -63401.714% |
| Shattuck Labs, Inc. | -2.38 Million USD | -4559.455% |
| CervoMed Inc. | -1.29 Million USD | -8490.421% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -4516.867% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -2226.314% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 4597.289% |
| Moolec Science SA | -143.3 Thousand USD | -77446.492% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -27135.252% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -4059.717% |
| AnaptysBio, Inc. | 14.78 Million USD | 851.83% |
| Design Therapeutics, Inc. | -537 Thousand USD | -20594.227% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -25925.293% |
| NeurAxis, Inc. | 2.15 Million USD | 5252.677% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 5278.378% |
| Lumos Pharma, Inc. | 2 Million USD | 5637.02% |
| Achilles Therapeutics plc | -4.73 Million USD | -2248.8% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -63401.714% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -105060.161% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 451.018% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 12990.309% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -10668.217% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -143.98% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 258537.209% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -13419.221% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -844466.043% |
| Palisade Bio, Inc. | 246 Thousand USD | 45273.984% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -336651.515% |
| Beam Therapeutics Inc. | -59.67 Million USD | -86.231% |
| Neurogene Inc. | -3.26 Million USD | -3306.744% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 179.756% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -2909.967% |
| Sesen Bio, Inc. | 40 Million USD | 377.82% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -37316.835% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -2659.548% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -1061.698% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 889.261% |
| Athira Pharma, Inc. | -969 Thousand USD | -11368.318% |
| Vaccinex, Inc. | -16 Million USD | -594.376% |
| HCW Biologics Inc. | -574.82 Thousand USD | -19232.526% |
| XOMA Corporation | 3.86 Million USD | 2978.218% |
| Nektar Therapeutics | 53.47 Million USD | 307.801% |
| Arvinas, Inc. | 71.8 Million USD | 254.774% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | -33.15% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -77.026% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -34411.801% |
| Rezolute, Inc. | -36 Thousand USD | -308588.889% |
| Clene Inc. | 533 Thousand USD | 20949.531% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -8654728.66% |
| BeyondSpring Inc. | 1.75 Million USD | 6446.545% |
| Synlogic, Inc. | -1.92 Million USD | -5675.884% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -300245.946% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -1655.022% |
| Peak Bio, Inc. | 367.76 Thousand USD | 30316.794% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -486.025% |
| Krystal Biotech, Inc. | 47.6 Million USD | 333.438% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 178.763% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 2311.502% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -4191.951% |
| MannKind Corporation | 136.19 Million USD | 181.597% |
| Ikena Oncology, Inc. | -50.49 Million USD | -120.09% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 202.127% |
| Gossamer Bio, Inc. | -4.38 Million USD | -2434.276% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -43998.413% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -2222460.0% |
| Legend Biotech Corporation | 140.92 Million USD | 178.854% |
| Mural Oncology plc | -2.56 Million USD | -4229.1% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -20068.421% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -111028.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 635.453% |
| REGENXBIO Inc. | 53.02 Million USD | 309.561% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -1974.463% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -57666.342% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -6316.166% |
| Vaxart, Inc. | -60.76 Million USD | -82.888% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -42189.368% |
| Cellectis S.A. | 18 Thousand USD | 617477.778% |
| Longeveron Inc. | 221 Thousand USD | 50384.163% |
| Repare Therapeutics Inc. | -80.07 Million USD | -38.789% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 110.167% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -8487.944% |
| Revolution Medicines, Inc. | -399.66 Million USD | 72.195% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -317408.571% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 226891.837% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 101.291% |
| Denali Therapeutics Inc. | -93.34 Million USD | -19.051% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -443542.461% |
| Veru Inc. | 7.56 Million USD | 1568.795% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -73494.702% |
| Cingulate Inc. | -582.91 Thousand USD | -18964.088% |
| Passage Bio, Inc. | -3.72 Million USD | -2886.509% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -922583.494% |
| Exicure, Inc. | -1.42 Million USD | -7709.417% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -28915.144% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 4211.284% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -21576.111% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 263.121% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -74179.947% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -87.697% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 28521.483% |
| OmniAb, Inc. | 14.66 Million USD | 857.674% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 655.835% |
| Lipocine Inc. | -2.85 Million USD | -3798.109% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -5929.734% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -1847.905% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -7277.592% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 247.549% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -170866.154% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 231.831% |
| Ocugen, Inc. | -33.53 Million USD | -231.359% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -3414.485% |
| Q32 Bio Inc. | 578 Thousand USD | 19326.298% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -41835.094% |
| Alumis Inc. Common Stock | -1.28 Million USD | -8554.829% |
| Equillium, Inc. | 35.95 Million USD | 409.049% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -6410.135% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 22295.459% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -2688047.073% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -42806.564% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 26389.294% |
| Dominari Holdings Inc. | 2.03 Million USD | 5550.123% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -60469.79% |
| vTv Therapeutics Inc. | -13.59 Million USD | -717.418% |
| Bio-Techne Corporation | 773.07 Million USD | 114.375% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 741.654% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 124.117% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -9406.245% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -363.42% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 1050.056% |
| Nkarta, Inc. | -5.86 Million USD | -1793.474% |
| BioCardia, Inc. | -7.24 Million USD | -1433.011% |
| Iterum Therapeutics plc | -1.75 Million USD | -6250.171% |